-
公开(公告)号:US09534243B2
公开(公告)日:2017-01-03
申请号:US14174981
申请日:2014-02-07
申请人: John P. Marino , Zvi Kelman , Jerard Hurwitz , Gary G. Giulian
发明人: John P. Marino , Zvi Kelman , Jerard Hurwitz , Gary G. Giulian
IPC分类号: C12P21/06 , C12P19/32 , C07H19/10 , C07H19/207 , C12P19/30
CPC分类号: C12P19/32 , C07H19/10 , C07H19/207 , C12P19/305 , C12Y207/07 , Y02P20/52
摘要: A process for making a nucleotide analog includes combining a first substrate that includes a linker and a base with a second substrate to form a substrate composition. An enzyme contacts the substrate composition and catalyzes formation of the nucleotide analog from the first substrate and the second substrate. Additionally, a composition includes the first substrate, second substrate, the enzyme, the nucleotide analog, and optional additives.
摘要翻译: 制备核苷酸类似物的方法包括将包含接头和碱基的第一底物与第二底物组合以形成底物组合物。 酶与底物组合物接触并催化从第一底物和第二底物形成核苷酸类似物。 另外,组合物包括第一底物,第二底物,酶,核苷酸类似物和任选的添加剂。
-
公开(公告)号:US20160354491A1
公开(公告)日:2016-12-08
申请号:US15240512
申请日:2016-08-18
IPC分类号: A61K48/00
CPC分类号: A61K48/0066 , A61K38/1816 , A61K38/193 , A61K48/00 , C07H19/10 , C07H21/00 , C12N15/11 , C12N2310/321 , C12N2310/322 , C12N2310/335 , C12N2310/336 , C12N2320/30 , C12P19/34 , C12P21/00 , C12P21/005
摘要: The present disclosure provides modified nucleosides, nucleotides, and nucleic acids, and methods of using them.
-
公开(公告)号:US20160354490A1
公开(公告)日:2016-12-08
申请号:US15239329
申请日:2016-08-17
CPC分类号: A61K48/0066 , A61K38/1816 , A61K38/193 , A61K48/00 , C07H19/10 , C07H21/00 , C12N15/11 , C12N2310/321 , C12N2310/322 , C12N2310/335 , C12N2310/336 , C12N2320/30 , C12P19/34 , C12P21/00 , C12P21/005
摘要: The present disclosure provides modified nucleosides, nucleotides, and nucleic acids, and methods of using them.
-
公开(公告)号:US20160318969A1
公开(公告)日:2016-11-03
申请号:US15210509
申请日:2016-07-14
发明人: Anuj K Kuldipkumar , Ales Medek , Lori Ann Ferris , Praveen Mudunuri , Young Chun Jung , David Richard Willcox , Michael Waldo , William Aloysius Nugent
IPC分类号: C07H19/10 , A61K45/06 , A61K31/7072
CPC分类号: C07H19/10 , A61K31/7056 , A61K31/706 , A61K31/7064 , A61K31/7068 , A61K31/7072 , A61K38/00 , A61K45/06 , C07B2200/13 , C07H19/06 , A61K2300/00
摘要: The present application relates to solid state forms, for example, crystalline forms of 2′-C-methyluridine-5′-(O-phenyl-N—(S)-1-(isopropoxycarbonyl)ethyl)thiophosphoramidate, pharmaceutical compositions that can include one or more solid forms of 2′-C-methyluridine-5′-(O-phenyl-N—(S)-1-(isopropoxycarbonyl)ethyl)thiophosphoramidate, and methods of treating or ameliorating diseases and/or conditions with one or more solid forms of 2′-C-methyluridine-5′-(O-phenyl-N—(S)-1-(isopropoxycarbonyl)ethyl)thiophosphoramidate. Also disclosed herein are methods of treating diseases and/or conditions with one or more solid forms of 2′-C-methyluridine-5′-(O-phenyl-N—(S)-1-(isopropoxycarbonyl)ethyl)thiophosphoramidate in combination with one or more other agents.
摘要翻译: 本申请涉及固态形式,例如2'-C-甲基尿苷-5' - (O-苯基-N-(S)-1-(异丙氧基羰基)乙基)硫代磷酰胺的结晶形式,其可以包括 一种或多种固体形式的2'-C-甲基尿苷-5' - (O-苯基-N-(S)-1-(异丙氧基羰基)乙基)硫代磷酰胺酯,以及用一种或多种硫代磷酸酰胺酯治疗或改善疾病和/或病症的方法 更多固体形式的2'-C-甲基尿苷-5' - (O-苯基-N-(S)-1-(异丙氧基羰基)乙基)硫代磷酰胺。 本文还公开了组合治疗具有一种或多种固体形式的2'-C-甲基尿苷-5' - (邻苯基-N-(S)-1-(异丙氧基羰基)乙基)硫代磷酰胺的疾病和/或病症的方法 与一个或多个其他代理。
-
公开(公告)号:US20160318967A1
公开(公告)日:2016-11-03
申请号:US15215434
申请日:2016-07-20
IPC分类号: C07H19/06 , A61K31/7072 , A61K31/7068 , C07H19/20 , C07H19/16 , A61K31/708 , A61K31/7076 , A61K45/06 , C07H19/10
CPC分类号: C07H19/06 , A61K31/7068 , A61K31/7072 , A61K31/7076 , A61K31/708 , A61K45/06 , C07H19/10 , C07H19/16 , C07H19/20 , A61K2300/00
摘要: Disclosed herein are nucleosides, nucleotides and analogs thereof, pharmaceutical compositions that include one or more of nucleosides, nucleotides and analogs thereof, and methods of synthesizing the same. Also disclosed herein are methods of ameliorating and/or treating a paramyxovirus viral infection, with a nucleoside, a nucleotide and an analog thereof.
-
公开(公告)号:US09481703B2
公开(公告)日:2016-11-01
申请号:US14634449
申请日:2015-02-27
申请人: MEDIVIR AB
CPC分类号: C07H19/06 , A61K31/7072 , A61K45/06 , C07H19/073 , C07H19/10 , C07H19/11 , C07H19/16 , C07H19/173 , C07H19/20 , C07H19/213 , C07H23/00
摘要: The invention provides compounds of the formula: wherein B is a nucleobase selected from the groups (a) to (d): and the other variables are as defined in the claims, which are of use in the treatment or prophylaxis of hepatitis C virus infection, and related aspects.
摘要翻译: 本发明提供下式的化合物:其中B是选自(a) - (d)组的核碱基,其他变量如权利要求中所定义,其用于治疗或预防丙型肝炎病毒感染 ,及相关方面。
-
公开(公告)号:US09447464B2
公开(公告)日:2016-09-20
申请号:US14072343
申请日:2013-11-05
发明人: Robin Emig , Lei Jia , Jeremiah Hanes , Lubomir Sebo
CPC分类号: C12Q1/6869 , C07H19/10 , C07H19/11 , C07H19/20 , C07H19/213 , C12Q1/6874 , C12Q2521/301 , C12Q2525/186 , C12Q2563/107 , C12Q2537/157 , C12Q2521/319 , C12Q2521/525
摘要: Methods, Compositions, and Systems are provided for nucleic acid sequencing where the sequential incorporation of nucleotides uses two distinct chemical steps. A plurality of nucleotide analogs, each having a labeled leaving group at its 3′ hydroxyl can be sequentially added to a growing strand in the presence of a selective cleaving activity that cleaves the 3′ hydroxyl leaving group preferentially after it has been incorporated. The selective cleaving agent can comprise an exonuclease activity, and the exonuclease activity can be a polymerase-associated exonuclease activity. Nucleotide analogs having labels on both a cleavable polyphosphate portion and on a 3′ hydroxyl leaving group can provide signals characteristic of nucleotide analog incorporation. Systems having illumination optics, collection optics, and substrates observe signals from the labels as they are being incorporated into a growing nucleic acid strand, allowing for the sequencing of template nucleic acids.
摘要翻译: 提供了用于核酸测序的方法,组合物和系统,其中连续掺入核苷酸使用两个不同的化学步骤。 在选择性切割活性的存在下,可以将多个在其3'羟基上具有标记的离去基团的核苷酸类似物依次加入到生长链中,该选择性裂解活性优选在其引入后优先切割3'羟基离去基团。 选择性切割剂可以包含核酸外切酶活性,并且核酸外切酶活性可以是聚合酶相关的外切核酸酶活性。 在可切割聚磷酸酯部分和3'羟基离去基团上具有标记的核苷酸类似物可以提供核苷酸类似物掺入特征的信号。 具有照明光学器件,收集光学元件和底物的系统在标记被并入生长的核酸链中观察信号,允许对模板核酸进行测序。
-
公开(公告)号:US20160244824A1
公开(公告)日:2016-08-25
申请号:US14460157
申请日:2014-08-14
发明人: Jonas Korlach , Jeffrey Wegener
IPC分类号: C12Q1/68
CPC分类号: C12Q1/6869 , C07H19/10 , C12Q1/6818 , C12Q1/6874 , G01N33/5308
摘要: Nucleic acid compositions, methods of making and using such compositions that comprise modular functional groups that can be configured to provide desired functionality to different nucleotide types through a swappable and preferably non-covalent linkage component. Such compositions are useful in a variety of applications including nucleic acid analyses.
摘要翻译: 核酸组合物,制备和使用这样的组合物的方法,所述组合物包含模块化官能团,其可被配置为通过可交换且优选非共价连接组分为不同核苷酸类型提供所需功能。 这样的组合物可用于各种应用,包括核酸分析。
-
公开(公告)号:US09410200B2
公开(公告)日:2016-08-09
申请号:US14857671
申请日:2015-09-17
CPC分类号: C12Q1/6869 , C07H19/10 , C07H19/20 , C07H21/00 , C12P19/34 , C12Q1/6806 , C12Q1/6818 , C12Q1/6823 , C12Q1/6834 , C12Q1/6874 , C12Q1/6876 , C12Q2525/186
摘要: Nucleosides and nucleotides are disclosed that are linked to detectable labels via a cleavable linker group.
-
公开(公告)号:US09410199B2
公开(公告)日:2016-08-09
申请号:US14821592
申请日:2015-08-07
发明人: Xiaohai Liu , John Milton , Silke Ruediger
IPC分类号: C12Q1/68 , C12P19/34 , C07H21/04 , C07H19/06 , C07H19/10 , C07H19/16 , C07H19/20 , C07H21/00
CPC分类号: C07H19/04 , C07H19/06 , C07H19/10 , C07H19/14 , C07H19/16 , C07H19/20 , C07H21/00 , C07H21/04 , C12Q1/6869 , C12Q1/6874 , Y10T436/143333 , C12Q2535/113 , C12Q2525/186
摘要: The invention provides a nucleotide or nucleoside having a base attached to a detectable label via a cleavable linker, characterized in that the cleavable linker contains a moiety selected from the group comprising: Formula (I) (wherein X is selected from the group comprising O, S, NH and NQ wherein Q is a C1-10 substituted or unsubstituted alkyl group, Y is selected from the group comprising O, S, NH and N(allyl), T is hydrogen or a C1-10 substituted or unsubstituted alkyl group and * indicates where the moiety is connected to the remainder of the nucleotide or nucleoside).
摘要翻译: 本发明提供了具有通过可切割接头连接到可检测标记的碱基的核苷酸或核苷,其特征在于所述可切割连接体含有选自以下的部分:式(I)(其中X选自O, S,NH和NQ,其中Q是C 1-10取代或未取代的烷基,Y选自O,S,NH和N(烯丙基),T是氢或C 1-10取代或未取代的烷基, *表示部分连接到核苷酸或核苷的剩余部分)。
-
-
-
-
-
-
-
-
-